View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Sponsored by Technobis Crystallisation Systems

Cannabinoids Screening for Co-Crystals with a Solubility-Based Approach

Free White Paper

Cannabinoids Screening for Co-Crystals with a Solubility-Based Approach

By Technobis Crystallisation Systems

Cannabinoids Screening for Co-Crystals with a Solubility-Based Approach

By Technobis Crystallisation Systems
Enter your details to receive the free paper:

Within the pharma industry active ingredients are commonly formulated as solid dosages, however the properties of the solid form of the actives are not always ideal. Therefore, crystal engineering is often employed to improve properties. Co-crystals are a form of crystal engineering that is gaining an increased level of interest within pharma.

Co-crystals are a multicomponent complex, similar to salts, solvates and hydrates, where a second molecule is incorporated into the crystal lattice. However, unlike other complexes, the second molecule must be neutral and not a solvent.

To read more, please download this free white paper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU